Avenda Health’s Brittany Berry on bridging the reimbursement gap, proving economic value and turning AI innovation into sustainable commercial scale...
Cedars-Sinai’s Phase I GlutaPanc trial challenges conventional thinking around glutamine metabolism, with L-glutamine plus standard chemotherapy demonstrating encouraging survival and tumour-response signals in advanced pancreatic cancer....
Deal Positions Stryker To Expand Into High Growth Intravascular Lithotripsy Segment And Address Complex Calcified Arterial Disease...
The company aims to bridge a critical gap in the early and accurate detection of neurodegenerative diseases...
On International Women’s Day, a health-tech leader highlights how women are increasingly shaping policy, innovation, and patient-centric digital transformation...
Carvolix aims to simplify some of the most complex cardiovascular and stroke interventions, making them safer, scalable, and more accessible worldwide...
As QMSR, EUDAMED, cybersecurity, and AI controls widen the compliance surface, leading manufacturers are converting the same pressures into measurable gains in quality, delivery, cost, and speed through digitally fluent teams, auditable AI, resilient supply networks, and data centric regulatory operations....
Next-generation variable-rate contrast management system designed to advance precision, safety, and efficiency in image-guided cardiovascular procedures...
The child underwent a haploidentical hematopoietic stem cell transplantation, the only curative treatment available for this condition...
This collaboration will see the two companies combine Fujitsu Japan's knowledge in the medical field and advanced technologies, including AI...
